Hermann Neugebauer
Overview
Explore the profile of Hermann Neugebauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barba L, Vollmuth C, Halbgebauer S, Ungethum K, Hametner C, Essig F, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16581.
PMID: 39714176
Background: We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after...
2.
Kapapa T, Pala A, Alber B, Mauer U, Harth A, Neugebauer H, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407749
The aim of this study was to investigate the use of image-guided volumetry in cerebellar infarction during the decision-making process for surgery. Particular emphasis was placed on the ratio of...
3.
Mrochen A, Alhaj Omar O, Pelz J, Michalski D, Neugebauer H, Lehrieder D, et al.
Eur Stroke J
. 2024 Oct;
:23969873241289360.
PMID: 39397354
Introduction: Neurocritical care patients with neurovascular disease often face poor long-term outcomes, highlighting the pivotal role of evidence-based interventions. Although International Guidelines emphasize managing basic physiological parameters like temperature, blood...
4.
Kollikowski A, Pham M, Marz A, Feick J, Vogt M, Xiong Y, et al.
EBioMedicine
. 2024 Apr;
103:105095.
PMID: 38579365
Background: Matrix metalloproteinases (MMPs) are implied in blood-brain barrier degradation and haemorrhagic transformation following ischaemic stroke, but their local relevance in the hyperacute disease phase is unknown. We aimed to...
5.
Vollmuth C, Fiessler C, Montellano F, Kollikowski A, Essig F, Oeckl P, et al.
Eur Stroke J
. 2024 Feb;
9(3):751-762.
PMID: 38400734
Introduction: Blood-based biomarkers may improve prediction of functional outcome in patients with acute ischemic stroke. The role of neurofilament light chain (NfL) and glial fibrillary acidic (GFAP) as potential biomarkers...
6.
Barba L, Vollmuth C, Abu-Rumeileh S, Halbgebauer S, Oeckl P, Steinacker P, et al.
Sci Rep
. 2023 Nov;
13(1):20941.
PMID: 38017278
We aimed to assess the prognostic value of serum β-synuclein (β-syn), neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in patients with moderate-to-severe acute ischemic stroke. We measured...
7.
Traub J, Schliesser M, Morbach C, Frantz S, Pham M, Stork S, et al.
ESC Heart Fail
. 2023 Jul;
10(5):3203-3208.
PMID: 37401264
Aims: Mild cognitive impairment and dementia are common and serious co-morbidities in people with chronic heart failure (HF) as they increase hospitalization rates, mortality and health care costs. Upon other...
8.
Lehrieder D, Muller H, Kassubek J, Hecht N, Thomalla G, Michalski D, et al.
J Neurol
. 2023 May;
270(8):4080-4089.
PMID: 37162579
Introduction: In malignant cerebral infarction decompressive hemicraniectomy has demonstrated beneficial effects, but the optimum size of hemicraniectomy is still a matter of debate. Some surgeons prefer a large-sized hemicraniectomy with...
9.
Lange F, Eldebakey H, Hilgenberg A, Weigl B, Eckert M, DeSunda A, et al.
Parkinsonism Relat Disord
. 2023 Mar;
109:105347.
PMID: 36870157
Background: Deep brain stimulation of the subthalamic nucleus is an effective treatment of Parkinson's disease, yet it is often associated with a general deterioration of speech intelligibility. Clustering the phenotypes...
10.
Haarmann A, Vollmuth C, Kollikowski A, Heuschmann P, Pham M, Stoll G, et al.
Cells
. 2023 Jan;
12(2).
PMID: 36672223
Now that mechanical thrombectomy has substantially improved outcomes after large-vessel occlusion stroke in up to every second patient, futile reperfusion wherein successful recanalization is not followed by a favorable outcome...